BIOLEGEND FROM REVVITY
LIVE

Serial Number

99562551

Owner

BioLegend, Inc.

Attorney

Kevin Oliver

Filing Date

Dec 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BIOLEGEND FROM REVVITY Trademark

Serial Number: 99562551

BIOLEGEND FROM REVVITY is a trademark filed by BioLegend, Inc. on December 23, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BioLegend, Inc. (8 trademarks)

8999 BioLegend Way
San Diego, CA 92121

Entity Type: 03

Revvity, Inc.

77 4th Avenue, Floor 2
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

December 23, 2025

Registration Date

Not Registered

Goods & Services

Antibody reagents used for the detection of antigens in cells and tissue for medical purposes

Providing online non-downloadable computer software platforms for scientific research; Providing online non-downloadable computer software platforms for use in molecular biology; Providing online non-downloadable computer software platforms for cell cycle analysis; Providing online non-downloadable computer software platforms for gene expression profiling; Providing online non-downloadable computer software platforms for cell sorting; Providing online non-downloadable computer software platforms for protein expression; Providing online non-downloadable computer software platforms for importing and analyzing data; Providing online non-downloadable computer software platforms for database management; Providing online non-downloadable computer software platforms for organizing and managing experiments; Providing online non-downloadable computer software platforms for analysis of scientific data and information for use in analyzing cells and particles using reflective and fluorescent properties produced by a flow cytometer apparatus or device; Compiling data for research purposes in the field of medical science and medical consultancy; Providing online non-downloadable computer software platforms for use in biotechnology research; Research and development services in the field of antibodies; Custom design and development of chemical reagents and biochemical assays; Research and development of conjugated antibodies

Reagents for scientific and research use; Chemical preparations for scientific purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Biochemical preparations for scientific use; Biochemical reagents, other than for medical or veterinary purposes; Biological preparation for use in cell cultures other than for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Buffer solutions for use in analytical chemistry; Biological preparations for use in the manufacture of pharmaceuticals; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; Enzymes for scientific and research purposes; Assays for scientific and research use; Cell culture reagents for scientific and research use; In vitro diagnostic reagents for scientific purposes

Laboratory equipment and supplies, namely, test tubes; Laboratory equipment and supplies, namely, centrifuge tubes; Laboratory apparatus and instruments for extracting cells and cellular components for processing biological material, sample preparation, extracting cells, isolating cells, and tissue dissociation, not for medical purposes; Disposable plastic bioreactors for cell culturing

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 1, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 1, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 1, 2026 CNSL
ASSIGNED TO EXAMINER
Apr 24, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 23, 2025 MAFR
NEW APPLICATION ENTERED
Dec 23, 2025 NWAP